Table of Contents    
CORRESPONDENCE
Year : 2017  |  Volume : 8  |  Issue : 4  |  Page : 176
 

Vitamin B12 supplementation and methylcobalamin: Use or misuse


Department of Neurology, Dr. S. N. Medical College, Jodhpur, Rajasthan, India

Date of Submission07-Aug-2017
Date of Acceptance14-Dec-2017
Date of Web Publication2-Feb-2018

Correspondence Address:
Khichar Purnaram Shubhakaran
Department of Neurology, Dr. S. N. Medical College, Jodhpur, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jpp.JPP_109_17

Rights and Permissions

 



How to cite this article:
Shubhakaran KP. Vitamin B12 supplementation and methylcobalamin: Use or misuse. J Pharmacol Pharmacother 2017;8:176

How to cite this URL:
Shubhakaran KP. Vitamin B12 supplementation and methylcobalamin: Use or misuse. J Pharmacol Pharmacother [serial online] 2017 [cited 2019 Nov 13];8:176. Available from: http://www.jpharmacol.com/text.asp?2017/8/4/176/224588




Sir,

We read an interesting letter by Kamath and Pemminati.[1] Here, we would like to share our view and experience:

  1. Methylcobalamin (MeCbl) or Vitamin B12 is many a times also used for radicular pain and many other nonspecific symptoms besides being used for its hematological and neurological disorders and neuropathies by registered medical practitioners, quacks, and general practitioners as an initial therapy before such patients are investigated or arrive to neurologists. At times, such patients do develop a habit of taking such treatments whenever they have recurrence of such symptoms
  2. Once the MeCbl costing more and with other combinations entered the market, the pharmaceutical companies became successful in replacing it with cyanocobalamin by one or the other means. Many such combinations were ultimately banned by the Indian government very recently
  3. The eminent authors have very well pointed out that there should be well-designed controlled trials comparing the various forms of Vitamin B12.


Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Kamath A, Pemminati S. Methylcobalamin in vitamin B12 deficiency: To give or not to give? J Pharmacol Pharmacother 2017;8:33-4.  Back to cited text no. 1
[PUBMED]  [Full text]  




 

Top
Print this article  Email this article
 
 
  Search
 
  
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (185 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1744    
    Printed62    
    Emailed0    
    PDF Downloaded259    
    Comments [Add]    

Recommend this journal